Drug treatment of inborn errors of metabolism

A systematic review

Majid Alfadhel, Khalid Al-Thihli, Hiba Moubayed, Wafaa Eyaid, Majed Al-Jeraisy

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background: The treatment of inborn errors of metabolism (IEM) has seen significant advances over the last decade. Many medicines have been developed and the survival rates of some patients with IEM have improved. Dosages of drugs used for the treatment of various IEM can be obtained from a range of sources but tend to vary among these sources. Moreover, the published dosages are not usually supported by the level of existing evidence, and they are commonly based on personal experience. Methods: A literature search was conducted to identify key material published in English in relation to the dosages of medicines used for specific IEM. Textbooks, peer reviewed articles, papers and other journal items were identified. The PubMed and Embase databases were searched for material published since 1947 and 1974, respectively. The medications found and their respective dosages were graded according to their level of evidence, using the grading system of the Oxford Centre for Evidence-Based Medicine. Results: 83 medicines used in various IEM were identified. The dosages of 17 medications (21%) had grade 1 level of evidence, 61 (74%) had grade 4, two medications were in level 2 and 3 respectively, and three had grade 5. Conclusions: To the best of our knowledge, this is the first review to address this matter and the authors hope that it will serve as a quickly accessible reference for medications used in this important clinical field.

Original languageEnglish
Pages (from-to)454-461
Number of pages8
JournalArchives of Disease in Childhood
Volume98
Issue number6
DOIs
Publication statusPublished - Jun 2013

Fingerprint

Inborn Errors Metabolism
Pharmaceutical Preparations
Therapeutics
Textbooks
Evidence-Based Medicine
PubMed
Survival Rate
Databases

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Drug treatment of inborn errors of metabolism : A systematic review. / Alfadhel, Majid; Al-Thihli, Khalid; Moubayed, Hiba; Eyaid, Wafaa; Al-Jeraisy, Majed.

In: Archives of Disease in Childhood, Vol. 98, No. 6, 06.2013, p. 454-461.

Research output: Contribution to journalArticle

Alfadhel, Majid ; Al-Thihli, Khalid ; Moubayed, Hiba ; Eyaid, Wafaa ; Al-Jeraisy, Majed. / Drug treatment of inborn errors of metabolism : A systematic review. In: Archives of Disease in Childhood. 2013 ; Vol. 98, No. 6. pp. 454-461.
@article{55cb3f7ae2494f42b6d677e21d8d9a67,
title = "Drug treatment of inborn errors of metabolism: A systematic review",
abstract = "Background: The treatment of inborn errors of metabolism (IEM) has seen significant advances over the last decade. Many medicines have been developed and the survival rates of some patients with IEM have improved. Dosages of drugs used for the treatment of various IEM can be obtained from a range of sources but tend to vary among these sources. Moreover, the published dosages are not usually supported by the level of existing evidence, and they are commonly based on personal experience. Methods: A literature search was conducted to identify key material published in English in relation to the dosages of medicines used for specific IEM. Textbooks, peer reviewed articles, papers and other journal items were identified. The PubMed and Embase databases were searched for material published since 1947 and 1974, respectively. The medications found and their respective dosages were graded according to their level of evidence, using the grading system of the Oxford Centre for Evidence-Based Medicine. Results: 83 medicines used in various IEM were identified. The dosages of 17 medications (21{\%}) had grade 1 level of evidence, 61 (74{\%}) had grade 4, two medications were in level 2 and 3 respectively, and three had grade 5. Conclusions: To the best of our knowledge, this is the first review to address this matter and the authors hope that it will serve as a quickly accessible reference for medications used in this important clinical field.",
author = "Majid Alfadhel and Khalid Al-Thihli and Hiba Moubayed and Wafaa Eyaid and Majed Al-Jeraisy",
year = "2013",
month = "6",
doi = "10.1136/archdischild-2012-303131",
language = "English",
volume = "98",
pages = "454--461",
journal = "Archives of Disease in Childhood",
issn = "1468-2044",
publisher = "BMJ Publishing Group",
number = "6",

}

TY - JOUR

T1 - Drug treatment of inborn errors of metabolism

T2 - A systematic review

AU - Alfadhel, Majid

AU - Al-Thihli, Khalid

AU - Moubayed, Hiba

AU - Eyaid, Wafaa

AU - Al-Jeraisy, Majed

PY - 2013/6

Y1 - 2013/6

N2 - Background: The treatment of inborn errors of metabolism (IEM) has seen significant advances over the last decade. Many medicines have been developed and the survival rates of some patients with IEM have improved. Dosages of drugs used for the treatment of various IEM can be obtained from a range of sources but tend to vary among these sources. Moreover, the published dosages are not usually supported by the level of existing evidence, and they are commonly based on personal experience. Methods: A literature search was conducted to identify key material published in English in relation to the dosages of medicines used for specific IEM. Textbooks, peer reviewed articles, papers and other journal items were identified. The PubMed and Embase databases were searched for material published since 1947 and 1974, respectively. The medications found and their respective dosages were graded according to their level of evidence, using the grading system of the Oxford Centre for Evidence-Based Medicine. Results: 83 medicines used in various IEM were identified. The dosages of 17 medications (21%) had grade 1 level of evidence, 61 (74%) had grade 4, two medications were in level 2 and 3 respectively, and three had grade 5. Conclusions: To the best of our knowledge, this is the first review to address this matter and the authors hope that it will serve as a quickly accessible reference for medications used in this important clinical field.

AB - Background: The treatment of inborn errors of metabolism (IEM) has seen significant advances over the last decade. Many medicines have been developed and the survival rates of some patients with IEM have improved. Dosages of drugs used for the treatment of various IEM can be obtained from a range of sources but tend to vary among these sources. Moreover, the published dosages are not usually supported by the level of existing evidence, and they are commonly based on personal experience. Methods: A literature search was conducted to identify key material published in English in relation to the dosages of medicines used for specific IEM. Textbooks, peer reviewed articles, papers and other journal items were identified. The PubMed and Embase databases were searched for material published since 1947 and 1974, respectively. The medications found and their respective dosages were graded according to their level of evidence, using the grading system of the Oxford Centre for Evidence-Based Medicine. Results: 83 medicines used in various IEM were identified. The dosages of 17 medications (21%) had grade 1 level of evidence, 61 (74%) had grade 4, two medications were in level 2 and 3 respectively, and three had grade 5. Conclusions: To the best of our knowledge, this is the first review to address this matter and the authors hope that it will serve as a quickly accessible reference for medications used in this important clinical field.

UR - http://www.scopus.com/inward/record.url?scp=84877587296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877587296&partnerID=8YFLogxK

U2 - 10.1136/archdischild-2012-303131

DO - 10.1136/archdischild-2012-303131

M3 - Article

VL - 98

SP - 454

EP - 461

JO - Archives of Disease in Childhood

JF - Archives of Disease in Childhood

SN - 1468-2044

IS - 6

ER -